OPGEN INC 4
4 · OPGEN INC · Filed May 12, 2015
Insider Transaction Report
Form 4
OPGEN INCOPGN,OPGNW
Ushio Misti
Director
Transactions
- Conversion
2015 Convertible Notes
2015-05-08−260,043→ 0 total(indirect: See footnote)→ Common Stock (260,043 underlying) - Conversion
Common Stock
2015-05-08+260,043→ 1,409,796 total(indirect: See footnote) - Conversion
2014 Convertible Notes
2015-05-08−209,020→ 0 total(indirect: See footnote)→ Common Stock (209,020 underlying) - Purchase
Common Stock
2015-05-08$6.00/sh+300,833$1,804,998→ 330,716 total(indirect: See footnote) - Conversion
Common Stock
2015-05-08+610,017→ 940,733 total(indirect: See footnote) - Conversion
Series A Redeemable Convertible Preferred Stock
2015-05-08−610,017→ 0 total(indirect: See footnote)→ Common Stock (610,017 underlying) - Purchase
Warrants
2015-05-08+300,833→ 300,833 total(indirect: See footnote)Exercise: $6.60From: 2015-05-08Exp: 2020-05-08→ Common Stock (300,833 underlying) - Conversion
Common Stock
2015-05-08+209,020→ 1,149,753 total(indirect: See footnote)
Footnotes (4)
- [F1]Series A Redeemable Convertible Preferred Stock automatically converted into common stock on a 1-to-1 basis upon the consummation of the Company's initial public offering.
- [F2]The 2014 Convertible Notes automatically converted into shares of Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of one share of Series A Preferred Stock for every $1.00 of principal converted. Each share of Series A Preferred Stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
- [F3]The 2015 Convertible Notes converted into Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of 1.25 shares of Series A Preferred Stock for each $1.00 of principal converted. Each share of Series A Preferred stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
- [F4]The securities are directly held by Harris & Harris Group, Inc. Dr. Ushio is Chief Strategy Officer and Managing Director of Harris & Harris Group, Inc., and may be deemed to have shared voting power over the shares owned by Harris & Harris Group, Inc. Dr. Ushio disclaims beneficial ownership of all shares held by Harris & Harris Group, Inc., except to the extent of her actual pecuniary interest therein.